Please enable JavaScript.
Coggle requires JavaScript to display documents.
Novartis Annual Report (Novartis Overall (Performance Driver (Top 5…
Novartis Annual Report
Novartis Overall
Financial performance
2017 net sales by geographical region
- Europe(% of net sales and in USD)
- United States
- Asia/Africa/Australia
- Canada and Latin America
2017 net sales by division
- Innovative Medicines
- Sandoz
- Alcon
in USD millions, % growth in constant currencies and divisional share of
net sales
Overall financial performance.
- Net sale in 2017 ($)
- Sales evolution 2013-17
- R&D expense in 2017(% of net sales)
- R&D expense evolution 2013-17
Performance Driver
-
-
Clinical trials outcomes
1.Psoriasis clearance
- Neuroscience
- Eye care
- Biosimilars
- Liver disease
- Malaria
-
Innovative Medicine
Financial performance
-
Innovative Medicines 2017 net sales
by business unit and franchise
- ONCOLOGY
- PHARMACE UTICA LS
2.1 OPHTHALMOLOGY
2.2 IMMUNOLOGY AND
DERMATOLOGY
2.3 NEUROSCIENCE
2.4 RESPIRA TORY
2.5 CAR DIO-METABOLIC
2.6 ESTABLISHED MEDICINES
-
Sandoz
Financial Performance
Net sales in 2017 and % change from 2016
- @ Overall
- @ Retail Generic
- @ Biopharma
- @ Anti-Infectives
Performance Driver
Key products
- @ Retail Generic
- @ Biopharma
- @ Anti-Infectives
Submission/Approval/Launch/Highlights
- @ Retail Generic
- @ Biopharma
- @ Anti-Infectives
Alcon
Financial Performance
Net sales in 2017 and % change from 2016
- @ Overall Alcon
- @ Surgical
- @ Vision Care
Performance Driver
Key products
- @ Surgical
- @ Vision Care
Submission/Approval/Launch/Highlights
- @ Surgical
- @ Vision Care